N-[3-(4-acetylphenyl)-1H-indazol-5-yl]-2-(3,4-dimethoxyphenyl)acetamide;N-[3-(4-acetylphenyl)-1H-indazol-5-yl]-2-pyridin-2-ylacetamide;N-[3-(1-benzofuran-2-yl)-1H-indazol-5-yl]furan-2-carboxamide;N-[3-(1-benzofuran-2-yl)-1H-indazol-5-yl]-2-hydroxy-2-phenylacetamide;N-(3-naphthalen-2-yl-1H-indazol-5-yl)-4-oxopentanamide

C112H90N16O14 — CID 158203670

IUPACN-[3-(4-acetylphenyl)-1H-indazol-5-yl]-2-(3,4-dimethoxyphenyl)acetamide;N-[3-(4-acetylphenyl)-1H-indazol-5-yl]-2-pyridin-2-ylacetamide;N-[3-(1-benzofuran-2-yl)-1H-indazol-5-yl]furan-2-carboxamide;N-[3-(1-benzofuran-2-yl)-1H-indazol-5-yl]-2-hydroxy-2-phenylacetamide;N-(3-naphthalen-2-yl-1H-indazol-5-yl)-4-oxopentanamide
SMILESCC(=O)CCC(=O)Nc1ccc2[nH]nc(-c3ccc4ccccc4c3)c2c1.CC(=O)c1ccc(-c2n[nH]c3ccc(NC(=O)Cc4ccccn4)cc23)cc1.COc1ccc(CC(=O)Nc2ccc3[nH]nc(-c4ccc(C(C)=O)cc4)c3c2)cc1OC.O=C(Nc1ccc2[nH]nc(-c3cc4ccccc4o3)c2c1)C(O)c1ccccc1.O=C(Nc1ccc2[nH]nc(-c3cc4ccccc4o3)c2c1)c1ccco1
InChIInChI=1S/C25H23N3O4.C23H17N3O3.C22H18N4O2.C22H19N3O2.C20H13N3O3/c1-15(29)17-5-7-18(8-6-17)25-20-14-19(9-10-21(20)27-28-25)26-24(30)13-16-4-11-22(31-2)23(12-16)32-3;27-22(14-6-2-1-3-7-14)23(28)24-16-10-11-18-17(13-16)21(26-25-18)20-12-15-8-4-5-9-19(15)29-20;1-14(27)15-5-7-16(8-6-15)22-19-12-18(9-10-20(19)25-26-22)24-21(28)13-17-4-2-3-11-23-17;1-14(26)6-11-21(27)23-18-9-10-20-19(13-18)22(25-24-20)17-8-7-15-4-2-3-5-16(15)12-17;24-20(17-6-3-9-25-17)21-13-7-8-15-14(11-13)19(23-22-15)18-10-12-4-1-2-5-16(12)26-18/h4-12,14H,13H2,1-3H3,(H,26,30)(H,27,28);1-13,22,27H,(H,24,28)(H,25,26);2-12H,13H2,1H3,(H,24,28)(H,25,26);2-5,7-10,12-13H,6,11H2,1H3,(H,23,27)(H,24,25);1-11H,(H,21,24)(H,22,23)
InChIKeyGBFVANNLYQCQRX-UHFFFAOYSA-N
MW1884.05 g/mol
LogP22.80
Rot. Bonds24

About N-[3-(4-acetylphenyl)-1H-indazol-5-yl]-2-(3,4-dimethoxyphenyl)acetamide;N-[3-(4-acetylphenyl)-1H-indazol-5-yl]-2-pyridin-2-ylacetamide;N-[3-(1-benzofuran-2-yl)-1H-indazol-5-yl]furan-2-carboxamide;N-[3-(1-benzofuran-2-yl)-1H-indazol-5-yl]-2-hydroxy-2-phenylacetamide;N-(3-naphthalen-2-yl-1H-indazol-5-yl)-4-oxopentanamide

N-[3-(4-acetylphenyl)-1H-indazol-5-yl]-2-(3,4-dimethoxyphenyl)acetamide;N-[3-(4-acetylphenyl)-1H-indazol-5-yl]-2-pyridin-2-ylacetamide;N-[3-(1-benzofuran-2-yl)-1H-indazol-5-yl]furan-2-carboxamide;N-[3-(1-benzofuran-2-yl)-1H-indazol-5-yl]-2-hydroxy-2-phenylacetamide;N-(3-naphthalen-2-yl-1H-indazol-5-yl)-4-oxopentanamide (PubChem CID 158203670) has the molecular formula C112H90N16O14 and a molecular weight of 1884.05 g/mol. Its IUPAC name is N-[3-(4-acetylphenyl)-1H-indazol-5-yl]-2-(3,4-dimethoxyphenyl)acetamide;N-[3-(4-acetylphenyl)-1H-indazol-5-yl]-2-pyridin-2-ylacetamide;N-[3-(1-benzofuran-2-yl)-1H-indazol-5-yl]furan-2-carboxamide;N-[3-(1-benzofuran-2-yl)-1H-indazol-5-yl]-2-hydroxy-2-phenylacetamide;N-(3-naphthalen-2-yl-1H-indazol-5-yl)-4-oxopentanamide.

Molecular Properties

Compound NameN-[3-(4-acetylphenyl)-1H-indazol-5-yl]-2-(3,4-dimethoxyphenyl)acetamide;N-[3-(4-acetylphenyl)-1H-indazol-5-yl]-2-pyridin-2-ylacetamide;N-[3-(1-benzofuran-2-yl)-1H-indazol-5-yl]furan-2-carboxamide;N-[3-(1-benzofuran-2-yl)-1H-indazol-5-yl]-2-hydroxy-2-phenylacetamide;N-(3-naphthalen-2-yl-1H-indazol-5-yl)-4-oxopentanamide
PubChem CID158203670
Molecular FormulaC112H90N16O14
Molecular Weight1884.05 g/mol
Exact Mass1882.68
IUPAC NameN-[3-(4-acetylphenyl)-1H-indazol-5-yl]-2-(3,4-dimethoxyphenyl)acetamide;N-[3-(4-acetylphenyl)-1H-indazol-5-yl]-2-pyridin-2-ylacetamide;N-[3-(1-benzofuran-2-yl)-1H-indazol-5-yl]furan-2-carboxamide;N-[3-(1-benzofuran-2-yl)-1H-indazol-5-yl]-2-hydroxy-2-phenylacetamide;N-(3-naphthalen-2-yl-1H-indazol-5-yl)-4-oxopentanamide
SMILESCC(=O)CCC(=O)Nc1ccc2[nH]nc(-c3ccc4ccccc4c3)c2c1.CC(=O)c1ccc(-c2n[nH]c3ccc(NC(=O)Cc4ccccn4)cc23)cc1.COc1ccc(CC(=O)Nc2ccc3[nH]nc(-c4ccc(C(C)=O)cc4)c3c2)cc1OC.O=C(Nc1ccc2[nH]nc(-c3cc4ccccc4o3)c2c1)C(O)c1ccccc1.O=C(Nc1ccc2[nH]nc(-c3cc4ccccc4o3)c2c1)c1ccco1
InChIInChI=1S/C25H23N3O4.C23H17N3O3.C22H18N4O2.C22H19N3O2.C20H13N3O3/c1-15(29)17-5-7-18(8-6-17)25-20-14-19(9-10-21(20)27-28-25)26-24(30)13-16-4-11-22(31-2)23(12-16)32-3;27-22(14-6-2-1-3-7-14)23(28)24-16-10-11-18-17(13-16)21(26-25-18)20-12-15-8-4-5-9-19(15)29-20;1-14(27)15-5-7-16(8-6-15)22-19-12-18(9-10-20(19)25-26-22)24-21(28)13-17-4-2-3-11-23-17;1-14(26)6-11-21(27)23-18-9-10-20-19(13-18)22(25-24-20)17-8-7-15-4-2-3-5-16(15)12-17;24-20(17-6-3-9-25-17)21-13-7-8-15-14(11-13)19(23-22-15)18-10-12-4-1-2-5-16(12)26-18/h4-12,14H,13H2,1-3H3,(H,26,30)(H,27,28);1-13,22,27H,(H,24,28)(H,25,26);2-12H,13H2,1H3,(H,24,28)(H,25,26);2-5,7-10,12-13H,6,11H2,1H3,(H,23,27)(H,24,25);1-11H,(H,21,24)(H,22,23)
InChIKeyGBFVANNLYQCQRX-UHFFFAOYSA-N
XLogP22.80
TPSA431.11 Ų
H-Bond Donors11
H-Bond Acceptors20
Rotatable Bonds24
Heavy Atoms142
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5001884.05
LogP ≤ 522.80
H-Bond Donors ≤ 511
H-Bond Acceptors ≤ 1020

Analyze N-[3-(4-acetylphenyl)-1H-indazol-5-yl]-2-(3,4-dimethoxyphenyl)acetamide;N-[3-(4-acetylphenyl)-1H-indazol-5-yl]-2-pyridin-2-ylacetamide;N-[3-(1-benzofuran-2-yl)-1H-indazol-5-yl]furan-2-carboxamide;N-[3-(1-benzofuran-2-yl)-1H-indazol-5-yl]-2-hydroxy-2-phenylacetamide;N-(3-naphthalen-2-yl-1H-indazol-5-yl)-4-oxopentanamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

2-(1,3-benzodioxol-5-yl)-N-[3-[2-(trifluoromethyl)phenyl]-1H-indazol-5-yl]acetamide;N-[3-(furan-2-yl)-1H-indazol-5-yl]-3-hydroxy-2-phenylpropanamide;2-methoxy-N-(3-thiophen-3-yl-1H-indazol-5-yl)acetamide;N-(3-naphthalen-2-yl-1H-indazol-5-yl)acetamide;N-(3-naphthalen-2-yl-1H-indazol-5-yl)methanesulfonamide;N-(3-thiophen-2-yl-1H-indazol-5-yl)pyridine-2-carboxamide
CID 161220655
2-[6-(3H-benzo[e]indazol-1-yl)-5-(oxadiazol-4-yl)-2-(1,3-oxazol-2-yl)-[1,3]oxazolo[5,4-b]pyridin-7-yl]benzo[e][1,3]benzoxazole
CID 141190427
4-(1H-indazol-3-yl)-2-(1,3-oxazol-2-yl)-5-pyrazolo[1,5-a]pyridin-2-yl-6-(1H-pyrazol-3-yl)-7-pyridin-2-yl-1,3-benzoxazole
CID 141223561
N-[3-(1-benzofuran-2-yl)-1H-indazol-5-yl]furan-2-carboxamide;N-[3-(1-benzofuran-2-yl)-1H-indazol-5-yl]furan-3-carboxamide;N-[3-(1-benzofuran-2-yl)-1H-indazol-5-yl]-2-pyridin-3-ylacetamide;N-[3-(1-benzofuran-2-yl)-1H-indazol-5-yl]-1,2,3,4-tetrahydronaphthalene-2-carboxamide;N-[3-(1-benzofuran-2-yl)-1H-indazol-5-yl]-2-thiophen-3-ylacetamide
CID 157120802
N-[3-[bis[(2-methyl-1,3-oxazol-5-yl)methyl]amino]propyl]-3-phenyl-1H-pyrazole-5-carboxamide;N-[3-[(3,4-dihydroxyphenyl)methyl-[(3-hydroxy-4-methylphenyl)methyl]amino]propyl]-3-phenyl-1H-pyrazole-5-carboxamide;N-[3-[(2-hydroxyphenyl)methylamino]propyl]-3-phenyl-1H-pyrazole-5-carboxamide;N-[3-(1H-indol-3-ylmethylamino)propyl]-3-phenyl-1H-pyrazole-5-carboxamide;N-[3-[(3-methoxyphenyl)methyl-[(5-methoxy-3-pyridinyl)methyl]amino]propyl]-3-phenyl-1H-pyrazole-5-carboxamide;N-[3-[(5-methoxy-3-pyridinyl)methylamino]propyl]-3-phenyl-1H-pyrazole-5-carboxamide;N-[3-[(2-methyl-1,3-oxazol-5-yl)methylamino]propyl]-3-phenyl-1H-pyrazole-5-carboxamide
CID 158193723
N-[3-(4-acetylphenyl)-1H-indazol-5-yl]-2-(3,4-dimethoxyphenyl)acetamide;N-[3-(4-acetylphenyl)-1H-indazol-5-yl]-2-pyridin-2-ylacetamide;N-[3-(1-benzofuran-2-yl)-1H-indazol-5-yl]-2-hydroxy-2-phenylacetamide;N-[3-(1-benzothiophen-2-yl)-1H-indazol-5-yl]-3-methoxypropanamide;N-(3-naphthalen-2-yl-1H-indazol-5-yl)-4-oxopentanamide
CID 158726615
N-(1,3-benzodioxol-5-ylmethyl)-3-pyridin-3-yl-1H-indazole-5-carboxamide;N-(cyclopropylmethyl)-3-naphthalen-2-yl-1H-indazole-5-carboxamide;N-[[(2R)-3,4-dihydro-2H-chromen-2-yl]methyl]-3-pyridin-2-yl-1H-indazole-5-carboxamide;N-[2-(furan-2-yl)-2-oxoethyl]-3-naphthalen-2-yl-1H-indazole-5-carboxamide;N-(1-methoxybutan-2-yl)-3-pyridin-2-yl-1H-indazole-5-carboxamide;3-naphthalen-2-yl-N-[(3R)-2-oxooxolan-3-yl]-1H-indazole-5-carboxamide
CID 159538752
N-[3-(1-benzofuran-2-yl)-1H-indazol-5-yl]-2-pyridin-3-ylacetamide;N-[3-(1-benzothiophen-2-yl)-1H-indazol-5-yl]-4-hydroxycyclohexane-1-carboxamide;4-(hydroxymethyl)-N-(3-naphthalen-2-yl-1H-indazol-5-yl)benzamide;2-hydroxy-N-(3-naphthalen-2-yl-1H-indazol-5-yl)-3-phenylpropanamide;4-methoxy-N-(3-naphthalen-2-yl-1H-indazol-5-yl)cyclohexane-1-carboxamide
CID 159709550
N-[3-(1-benzofuran-2-yl)-1H-indazol-5-yl]-2-pyridin-3-ylacetamide;N-[3-(1-benzofuran-2-yl)-1H-indazol-5-yl]-1,2,3,4-tetrahydronaphthalene-2-carboxamide;N-[3-(1-benzofuran-2-yl)-1H-indazol-5-yl]-2-thiophen-3-ylacetamide;N-[3-(1-benzothiophen-2-yl)-1H-indazol-5-yl]-4-hydroxycyclohexane-1-carboxamide;2-hydroxy-N-(3-naphthalen-2-yl-1H-indazol-5-yl)-3-phenylpropanamide
CID 160373973
(2S,4R)-N-[[2-[2-[2-[2-[[4-(furan-2-carbonyl)piperazin-1-yl]methyl]-4-(1H-indazol-4-yl)phenoxy]ethoxy]ethoxy]-4-(4-methyl-1,3-thiazol-5-yl)phenyl]methyl]-4-hydroxy-1-[(2S)-3-methyl-2-(3-oxo-1H-isoindol-2-yl)butanoyl]pyrrolidine-2-carboxamide
CID 175667470

Frequently Asked Questions

What is the IUPAC name of N-[3-(4-acetylphenyl)-1H-indazol-5-yl]-2-(3,4-dimethoxyphenyl)acetamide;N-[3-(4-acetylphenyl)-1H-indazol-5-yl]-2-pyridin-2-ylacetamide;N-[3-(1-benzofuran-2-yl)-1H-indazol-5-yl]furan-2-carboxamide;N-[3-(1-benzofuran-2-yl)-1H-indazol-5-yl]-2-hydroxy-2-phenylacetamide;N-(3-naphthalen-2-yl-1H-indazol-5-yl)-4-oxopentanamide?
The IUPAC name of N-[3-(4-acetylphenyl)-1H-indazol-5-yl]-2-(3,4-dimethoxyphenyl)acetamide;N-[3-(4-acetylphenyl)-1H-indazol-5-yl]-2-pyridin-2-ylacetamide;N-[3-(1-benzofuran-2-yl)-1H-indazol-5-yl]furan-2-carboxamide;N-[3-(1-benzofuran-2-yl)-1H-indazol-5-yl]-2-hydroxy-2-phenylacetamide;N-(3-naphthalen-2-yl-1H-indazol-5-yl)-4-oxopentanamide (CID 158203670) is N-[3-(4-acetylphenyl)-1H-indazol-5-yl]-2-(3,4-dimethoxyphenyl)acetamide;N-[3-(4-acetylphenyl)-1H-indazol-5-yl]-2-pyridin-2-ylacetamide;N-[3-(1-benzofuran-2-yl)-1H-indazol-5-yl]furan-2-carboxamide;N-[3-(1-benzofuran-2-yl)-1H-indazol-5-yl]-2-hydroxy-2-phenylacetamide;N-(3-naphthalen-2-yl-1H-indazol-5-yl)-4-oxopentanamide.
What is the SMILES notation for N-[3-(4-acetylphenyl)-1H-indazol-5-yl]-2-(3,4-dimethoxyphenyl)acetamide;N-[3-(4-acetylphenyl)-1H-indazol-5-yl]-2-pyridin-2-ylacetamide;N-[3-(1-benzofuran-2-yl)-1H-indazol-5-yl]furan-2-carboxamide;N-[3-(1-benzofuran-2-yl)-1H-indazol-5-yl]-2-hydroxy-2-phenylacetamide;N-(3-naphthalen-2-yl-1H-indazol-5-yl)-4-oxopentanamide?
The canonical SMILES for N-[3-(4-acetylphenyl)-1H-indazol-5-yl]-2-(3,4-dimethoxyphenyl)acetamide;N-[3-(4-acetylphenyl)-1H-indazol-5-yl]-2-pyridin-2-ylacetamide;N-[3-(1-benzofuran-2-yl)-1H-indazol-5-yl]furan-2-carboxamide;N-[3-(1-benzofuran-2-yl)-1H-indazol-5-yl]-2-hydroxy-2-phenylacetamide;N-(3-naphthalen-2-yl-1H-indazol-5-yl)-4-oxopentanamide is CC(=O)CCC(=O)Nc1ccc2[nH]nc(-c3ccc4ccccc4c3)c2c1.CC(=O)c1ccc(-c2n[nH]c3ccc(NC(=O)Cc4ccccn4)cc23)cc1.COc1ccc(CC(=O)Nc2ccc3[nH]nc(-c4ccc(C(C)=O)cc4)c3c2)cc1OC.O=C(Nc1ccc2[nH]nc(-c3cc4ccccc4o3)c2c1)C(O)c1ccccc1.O=C(Nc1ccc2[nH]nc(-c3cc4ccccc4o3)c2c1)c1ccco1.
What is the InChIKey of N-[3-(4-acetylphenyl)-1H-indazol-5-yl]-2-(3,4-dimethoxyphenyl)acetamide;N-[3-(4-acetylphenyl)-1H-indazol-5-yl]-2-pyridin-2-ylacetamide;N-[3-(1-benzofuran-2-yl)-1H-indazol-5-yl]furan-2-carboxamide;N-[3-(1-benzofuran-2-yl)-1H-indazol-5-yl]-2-hydroxy-2-phenylacetamide;N-(3-naphthalen-2-yl-1H-indazol-5-yl)-4-oxopentanamide?
The InChIKey is GBFVANNLYQCQRX-UHFFFAOYSA-N. The full InChI is InChI=1S/C25H23N3O4.C23H17N3O3.C22H18N4O2.C22H19N3O2.C20H13N3O3/c1-15(29)17-5-7-18(8-6-17)25-20-14-19(9-10-21(20)27-28-25)26-24(30)13-16-4-11-22(31-2)23(12-16)32-3;27-22(14-6-2-1-3-7-14)23(28)24-16-10-11-18-17(13-16)21(26-25-18)20-12-15-8-4-5-9-19(15)29-20;1-14(27)15-5-7-16(8-6-15)22-19-12-18(9-10-20(19)25-26-22)24-21(28)13-17-4-2-3-11-23-17;1-14(26)6-11-21(27)23-18-9-10-20-19(13-18)22(25-24-20)17-8-7-15-4-2-3-5-16(15)12-17;24-20(17-6-3-9-25-17)21-13-7-8-15-14(11-13)19(23-22-15)18-10-12-4-1-2-5-16(12)26-18/h4-12,14H,13H2,1-3H3,(H,26,30)(H,27,28);1-13,22,27H,(H,24,28)(H,25,26);2-12H,13H2,1H3,(H,24,28)(H,25,26);2-5,7-10,12-13H,6,11H2,1H3,(H,23,27)(H,24,25);1-11H,(H,21,24)(H,22,23).
What are the key properties of N-[3-(4-acetylphenyl)-1H-indazol-5-yl]-2-(3,4-dimethoxyphenyl)acetamide;N-[3-(4-acetylphenyl)-1H-indazol-5-yl]-2-pyridin-2-ylacetamide;N-[3-(1-benzofuran-2-yl)-1H-indazol-5-yl]furan-2-carboxamide;N-[3-(1-benzofuran-2-yl)-1H-indazol-5-yl]-2-hydroxy-2-phenylacetamide;N-(3-naphthalen-2-yl-1H-indazol-5-yl)-4-oxopentanamide?
N-[3-(4-acetylphenyl)-1H-indazol-5-yl]-2-(3,4-dimethoxyphenyl)acetamide;N-[3-(4-acetylphenyl)-1H-indazol-5-yl]-2-pyridin-2-ylacetamide;N-[3-(1-benzofuran-2-yl)-1H-indazol-5-yl]furan-2-carboxamide;N-[3-(1-benzofuran-2-yl)-1H-indazol-5-yl]-2-hydroxy-2-phenylacetamide;N-(3-naphthalen-2-yl-1H-indazol-5-yl)-4-oxopentanamide has a molecular weight of 1884.05 g/mol, XLogP of 22.80, 24 rotatable bonds, 11 hydrogen bond donors, and 20 hydrogen bond acceptors.
Where does this data come from?
All data for N-[3-(4-acetylphenyl)-1H-indazol-5-yl]-2-(3,4-dimethoxyphenyl)acetamide;N-[3-(4-acetylphenyl)-1H-indazol-5-yl]-2-pyridin-2-ylacetamide;N-[3-(1-benzofuran-2-yl)-1H-indazol-5-yl]furan-2-carboxamide;N-[3-(1-benzofuran-2-yl)-1H-indazol-5-yl]-2-hydroxy-2-phenylacetamide;N-(3-naphthalen-2-yl-1H-indazol-5-yl)-4-oxopentanamide is sourced from PubChem (CID 158203670), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).